Fig. 2From: Pharmacological and computational evaluation of fig for therapeutic potential in hyperactive gastrointestinal disorders3D-structures of protein targets: a adrenergic α1 receptor, b muscranic M1, c muscranic M3, d dopaminergic D2, e calmodulin, f mu-opioid, g voltage gated L-Type calcium channel, h histaminergic H1, i histaminergic H2, and (j) H+/K+ ATPase pumpBack to article page